Faslodex treatment to be launched by Wunderman

Share this article:
Wunderman has been chosen to launch a consumer campaign for AstraZeneca’s breast cancer treatment Faslodex. Wunderman will handle DTP relationship marketing efforts aimed at raising awareness in late-stage breast cancer patients, as well as DTC efforts. A print campaign is slated for summer 2007.

Share this article:
You must be a registered member of MMM to post a comment.

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.